Argentine < Australie < Autriche

Facettes : Author.f AffPays.f Mesh.f AffRegion.f AffVille.f AffOrg.f

List of bibliographic references

Number of relevant bibliographic references: 46.
[0-20] [0 - 20][0 - 46][20-40]

Ident.	Authors (with country if any)	Title
000011 (2020)	Morry Silberstein [Australie]	Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19?
000051 (2020)	Rakesh Awasthi [États-Unis] ; Lida Pacaud [États-Unis] ; Edward Waldron [États-Unis] ; Constantine S. Tam [Australie] ; Ulrich J Ger [Autriche] ; Peter Borchmann [Allemagne] ; Samantha Jaglowski [États-Unis] ; Stephen Ronan Foley [Canada] ; Koen Van Besien [États-Unis] ; Nina D. Wagner-Johnston [États-Unis] ; Marie José Kersten [Pays-Bas] ; Stephen J. Schuster [États-Unis] ; Gilles Salles [France] ; Richard T. Maziarz ; Özlem Anak [États-Unis] ; Christopher Del Corral [États-Unis] ; Jufen Chu [États-Unis] ; Irina Gershgorin [États-Unis] ; Iulian Pruteanu-Malinici [États-Unis] ; Abhijit Chakraborty [États-Unis] ; Karen Thudium Mueller [États-Unis] ; Edmund K. Waller [États-Unis]	Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL.
000165 (2020)	Ambrish Singh [Australie] ; Debashish Danda [Inde] ; Salman Hussain [Inde] ; Abul Kalam Najmi [Inde] ; Ashish Mathew [Inde] ; Ruchika Goel [Inde] ; Shaheen E. Lakhan [États-Unis] ; Belzik Tajudheen [Inde] ; Benny Antony [Australie]	Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials.
000296 (2019)	Boulos Haraoui [Canada] ; Gustavo Casado [Argentine] ; Lászl Czirják [Hongrie] ; Andrew Taylor [Australie] ; Lingli Dong [République populaire de Chine] ; Peter Button [Australie] ; Yves Luder [Suisse] ; Roberto Caporali [Italie]	Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies.
000305 (2019)	Amruta Trivedi [Australie] ; Constance Katelaris [Australie]	The use of biologic agents in the management of uveitis.
000380 (2019)	Cameron J. Williams [Australie] ; Andrew Foote [Australie] ; Philip Choi [Australie]	Pseudomonas meningoencephalitis masquerading as a stroke in a patient on tocilizumab.
000425 (2019)	Vivian P. Bykerk [États-Unis] ; Andrew J K. Östör [Australie] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Michael T. Nurmohamed [Pays-Bas] ; Yves Luder [Suisse] ; Paris N M. Sidiropoulos [États-Unis] ; Jenny Devenport [États-Unis] ; Jean Sibilia [France]	Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.
000613 (2018)	Anthony Michael Sammel ; Clare Louise Fraser [Australie]	Update on giant cell arteritis.
000626 (2018)	Rose I. Massolino [Australie] ; Pravin Hissaria [Australie] ; Anita Lee [Australie] ; Susanna M. Proudman [Australie]	Tocilizumab-induced drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient with rheumatoid arthritis.
000634 (2018)	Isobel Leake [Australie]	Tocilizumab or TNF inhibitors in RA?
000673 (2018)	Christopher J. Edwards [Royaume-Uni] ; Andrew J K. Östör [Australie] ; Barbara Naisbett-Groet ; Patrick Kiely [Royaume-Uni]	Tapering versus steady-state methotrexate in combination with tocilizumab for rheumatoid arthritis: a randomized, double-blind trial.
000758 (2018)	Graeme Jones [Australie] ; Elena Panova [Australie]	New insights and long-term safety of tocilizumab in rheumatoid arthritis.
000808 (2018)	Nirmala Chandralega Kampan [Australie] ; Sue D. Xiang [Australie] ; Orla M. Mcnally [Australie] ; Andrew N. Stephens [Australie] ; Michael A. Quinn [Australie] ; Magdalena Plebanski [Australie]	Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities.
000850 (2018)	Sanjoy Ketan Paul [Australie] ; Olga Montvida [Australie] ; Jennie H. Best [États-Unis] ; Sara Gale [États-Unis] ; Attila Pethoe-Schramm [Suisse] ; Khaled Sarsour [États-Unis]	Effectiveness of biologic and non-biologic antirheumatic drugs on anaemia markers in 153,788 patients with rheumatoid arthritis: New evidence from real-world data.
000927 (2018)	Paul Bird [Australie] ; Charles Peterfy [États-Unis] ; Peter Countryman [États-Unis] ; Hedley Griffiths [Australie] ; Rina Barrett [Australie] ; Peter Youssef [Australie] ; Fredrick Joshua [Australie] ; Stephen Hall [Australie]	AC-CUTE: An Open-Label Study to Evaluate Progression of Structural Joint Damage and Inflammation in Subjects with Moderate to Severe Rheumatoid Arthritis.
000929 (2018)	Graeme Jones [Australie] ; Stephen Hall [Australie] ; Paul Bird [Australie] ; Geoff Littlejohn [Australie] ; Kathleen Tymms [Australie] ; Peter Youssef [Australie] ; Eric Chung [Australie] ; Rina Barrett [Australie] ; Peter Button [Australie]	A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population.
000A35 (2017)	Lynden Roberts [Australie] ; Kathleen Tymms [Australie] ; Julien De Jager [Australie] ; Geoffrey Littlejohn [Australie] ; Hedley Griffiths [Australie] ; Dave Nicholls [Australie] ; Paul Bird [Australie] ; Jennifer Young [Australie] ; Julie Hill [Australie] ; Jane Zochling [Australie]	The CEDAR Study: A Longitudinal Study of the Clinical Effects of Conventional DMARDs and Biologic DMARDs in Australian Rheumatology Practice.
000B36 (2017)	Vibeke Strand [États-Unis] ; Margaret Michalska [États-Unis] ; Christine Birchwood [États-Unis] ; Jinglan Pei [États-Unis] ; Katie Tuckwell [États-Unis] ; Rebecca Finch [Royaume-Uni] ; Cem Gabay [Suisse] ; Arthur Kavanaugh [États-Unis] ; Graeme Jones [Australie]	Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials.
000B75 (2017)	Josef S. Smolen [Autriche] ; Robert Landewé [Pays-Bas] ; Johannes Bijlsma [Pays-Bas] ; Gerd Burmester [Allemagne] ; Katerina Chatzidionysiou [Suède] ; Maxime Dougados [France] ; Jackie Nam [Royaume-Uni] ; Sofia Ramiro [Pays-Bas] ; Marieke Voshaar [Pays-Bas] ; Ronald Van Vollenhoven [Pays-Bas] ; Daniel Aletaha [Autriche] ; Martin Aringer [Allemagne] ; Maarten Boers [Pays-Bas] ; Chris D. Buckley [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Vivian Bykerk [États-Unis] ; Mario Cardiel [Mexique] ; Bernard Combe [France] ; Maurizio Cutolo [Italie] ; Yvonne Van Eijk-Hustings [Pays-Bas] ; Paul Emery [Pays-Bas] ; Axel Finckh [Suisse] ; Cem Gabay [Suisse] ; Juan Gomez-Reino [Espagne] ; Laure Gossec [France] ; Jacques-Eric Gottenberg [France] ; Johanna M W. Hazes [Pays-Bas] ; Tom Huizinga [Pays-Bas] ; Meghna Jani [Royaume-Uni] ; Dmitry Karateev [Russie] ; Marios Kouloumas [Suisse] ; Tore Kvien [Norvège] ; Zhanguo Li [République populaire de Chine] ; Xavier Mariette [France] ; Iain Mcinnes [Royaume-Uni] ; Eduardo Mysler [Argentine] ; Peter Nash [Australie] ; Karel Pavelka [République tchèque] ; Gyula Po R [Hongrie] ; Christophe Richez [France] ; Piet Van Riel [Pays-Bas] ; Andrea Rubbert-Roth [Allemagne] ; Kenneth Saag [États-Unis] ; Jose Da Silva [Portugal] ; Tanja Stamm [Autriche] ; Tsutomu Takeuchi [Japon] ; René Westhovens [Belgique] ; Maarten De Wit [Pays-Bas] ; Désirée Van Der Heijde [Pays-Bas]	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.
000C78 (2016)	Kah-Lok Chan ; Stephen Lade ; H Miles Prince [Australie] ; Simon J. Harrison [Australie]	Update and new approaches in the treatment of Castleman disease.
000D25 (2016)	Ashley M. Hopkins [Australie] ; Susanna M. Proudman ; Agnes I. Vitry ; Michael J. Sorich ; Leslie G. Cleland ; Michael D. Wiese	Ten years of publicly funded biological disease-modifying antirheumatic drugs in Australia.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/AffPays.i -k "Australie" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/AffPays.i  \
                -Sk "Australie" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    AffPays.i
   |clé=    Australie
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021